AVIVAGEN INC (VIV.CA) Stock Price, Quote, News and Overview
TSX-V:VIV - TSX Venture Exchange - CA05382F2026 - Common Stock - Currency: CAD
VIV.CA Quote, Performance and Key Statistics
TSX-V:VIV (3/5/2024, 7:00:00 PM)
0.005
0 (0%)
The current stock price of VIV.CA is 0.005 CAD. In the past year, price decreased by -93.33%.
VIV.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.23 | 2.34B | ||
| CRON.CA | CRONOS GROUP INC | 14.5 | 1.01B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.1 | 731.47M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 54.73 | 599.77M | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 553.79M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.27 | 512.42M | ||
| ACB.CA | AURORA CANNABIS INC | 32.13 | 405.42M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 390.84M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 25.02 | 314.10M | ||
| HITI.CA | HIGH TIDE INC | N/A | 257.71M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | 29.83 | 239.65M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 219.33M |
Related stock screener links
About VIV.CA
Company Profile
Avivagen, Inc. engages in the development and commercialization of products for livestock. The company is headquartered in Ottawa, Ontario. The company went IPO on 2004-03-04. The firm is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. The company OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. The company offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.
Company Info
AVIVAGEN INC
100 Sussex Drive
Ottawa ONTARIO K1A 0R6 CA
CEO: Kym G.F. Anthony
Employees: 12
Phone: 16137022908
AVIVAGEN INC / VIV.CA FAQ
What is the stock price of AVIVAGEN INC today?
The current stock price of VIV.CA is 0.005 CAD.
What is the ticker symbol for AVIVAGEN INC stock?
The exchange symbol of AVIVAGEN INC is VIV and it is listed on the TSX Venture Exchange exchange.
On which exchange is VIV.CA stock listed?
VIV.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for AVIVAGEN INC stock?
9 analysts have analysed VIV.CA and the average price target is 1.02 CAD. This implies a price increase of 20300% is expected in the next year compared to the current price of 0.005. Check the AVIVAGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AVIVAGEN INC worth?
AVIVAGEN INC (VIV.CA) has a market capitalization of 388.47K CAD. This makes VIV.CA a Nano Cap stock.
How many employees does AVIVAGEN INC have?
AVIVAGEN INC (VIV.CA) currently has 12 employees.
What are the support and resistance levels for AVIVAGEN INC (VIV.CA) stock?
AVIVAGEN INC (VIV.CA) has a resistance level at 0.01. Check the full technical report for a detailed analysis of VIV.CA support and resistance levels.
Is AVIVAGEN INC (VIV.CA) expected to grow?
The Revenue of AVIVAGEN INC (VIV.CA) is expected to grow by 243.05% in the next year. Check the estimates tab for more information on the VIV.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AVIVAGEN INC (VIV.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VIV.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VIV.CA, evaluating the profitability, health, valuation and growth aspects
- AVIVAGEN INC (VIV.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AVIVAGEN INC (VIV.CA) Sales and EPS estimates to see what analysts future expectations are.
- AVIVAGEN INC (VIV.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AVIVAGEN INC (VIV.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AVIVAGEN INC (VIV.CA) Stock Chart to make your own analysis
- AVIVAGEN INC (VIV.CA) Latest news and press-releases to stay up to date.
Does AVIVAGEN INC (VIV.CA) stock pay dividends?
VIV.CA does not pay a dividend.
When does AVIVAGEN INC (VIV.CA) report earnings?
AVIVAGEN INC (VIV.CA) will report earnings on 2022-01-04.
What is the Price/Earnings (PE) ratio of AVIVAGEN INC (VIV.CA)?
AVIVAGEN INC (VIV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
VIV.CA Technical Analysis
VIV.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VIV.CA. VIV.CA may be in some trouble as it scores bad on both profitability and health.
VIV.CA Financial Highlights
Over the last trailing twelve months VIV.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1702.53% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VIV.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to VIV.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 31.33% and a revenue growth 243.05% for VIV.CA